8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001628280-26-036492
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading vtgn-20260518.htm…